A planned EO that would have greatly enhanced White House influence over grants at the NIH is “looking dead,” a source said.

Pending move comes over the objections of the NIH director.

While the phase 2 clinical trial results, shared by BioVie in a webinar on Tuesday, have yet to be peer-reviewed, investigators say they can inform a confirmatory phase 3 trial.

“Sickfluencers” are merely symptoms of a mass disabling event

A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (D...

Since the end of 2019, a coronavirus pandemic (SARS-CoV-2), responsible for severe acute respiratory syndrome, has spread worldwide. This pandemic, due to the spread of SARS-CoV-2, is similar to two p...

Media outlets that trumpet their journalistic integrity have used their prestige to launder an unproven, anti-science conspiracy theory about Long Covid.

Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem - a sugar-coated polymer nanoparticle - that can block Covid-19 from infecting human cells, reducing i...

Researchers linked antibodies that attack the body’s nervous system to some neurological symptoms of Long COVID.

The COVID-19 antiviral ensitrelvir (Xocova), was recently approved by the Food and Drug Administration. The oral drug was approved as PEP, or post-exposure prophylaxis, meaning it is taken within 72 h...